Everest Group’s 2026 AI Innovation Watch: A Definitive Guide for Clinical Leaders

Get exclusive access to Everest Group’s assessment of the AI landscape and discover the companies and capabilities driving the next generation of clinical trials.

Most AI initiatives fail as they move from pilot to production. Clinical leaders need a clear framework to identify the partners that offer true scale and maturity.

Everest Group evaluated 18 providers, and named Medidata the highest placed “Luminary” in their assessment—a ranking driven by our market performance, robust partnerships, and the maturity of our AI solutions.

What’s Inside the Report:

• The Innovation Framework: An inside look at how providers are benchmarked across maturity, scale, partnerships, and investment.
• The Path to 100% Adoption: Insights into why Medidata achieved the industry’s highest market adoption score.
• From Generative to Agentic AI: A breakdown of the AI applications that are actually moving the needle across the trial lifecycle.
• Investment Roadmap: Strategic guidance on where the industry’s leading providers are placing their bets for 2026 and beyond.

Complete the form to stay ahead of the innovation curve with the industry’s most comprehensive AI assessment.